Description
There are more than 100 types of cancers In Part II, head and neck cancer is d- affecting all parts of the human body. cussed. The global number of annual new More than 11 million people are diagnosed cases of this malignancy is ~500,000. These with cancer every year, and it is estimated malignancies include oral squamous cell that there will be 16 million new cases by carcinoma, salivary gland tumors, tons- the year 2020. In 2005, 7. 6 million peo- lar cancer, tongue cancer, nasopharyngeal ple died of cancer, that is, 13% of the 58 carcinoma, and retinoblastoma, which are million deaths worldwide. It is estimated detailed. In Part III, diagnosis, therapy, and that 9 million people will die from can- prognosis of thyroid carcinoma are d- cer worldwide in 2015 and 11. 4 million cussed. The global number of new cases of will die in 2030. More than 70% of all thyroid cancer is ~141,000, and the number cancer deaths occur in low and middle of worldwide thyroid mortalities is ~35,375. income countries. These statistics underlie The number of new cases of this cancer in the fact that cancer is the deadliest of all the United States is ~33,550. Molecular human diseases. The enormity of the glo- genetics of thyroid cancer, gene expr- bal healthcare costs as a result of cancer sion markers for diagnosis, papillary t- cannot be overemphasized.
Table of Contents
General Methods and Overviews.- Role of RNA Interference in Understanding the Molecular Basis of Cancer.- Cancer Biomarkers (An Overview).- Tumor Angiogenesis in Cancers: Expression of CD105 Marker.- Spindle Cell Oncocytoma of the Adenohypophysis: Integrated Clinicopathologic Diagnosis by Imaging, Histology, and Immunohistochemistry.- Disseminated Carcinoma of Unknown Primary Site: Detection with F-Fluorodeoxyglucose-Positron Emission Tomography.- Unknown Lymphadenopathy: Diagnosing Using an Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy.- Pretargeted Radioimmunotherapy in Cancer: An Overview.- Chemotherapy-Induced Neurotoxicity.- Multidrug Resistance.- Role of Antibodies in Cancer Treatment (An Overview).- Incorporating Pharmacogenomics into Cancer Therapy.- Cancer Stem Cells: An Overview.- Translating In Vitro Cell Lines Result into Clinical Practice.- Classification of Cancer Stage Using Patient’s Immune System.- Late Relapse of Germ Cell Malignancies: Incidence, Management, and Prognosis.- Head and Neck Cancer.- Head and Neck Squamous Cell Carcinoma: Therapy with Fusaric Acid/Paclitaxel.- Early Stage Oral Squamous Cell Carcinoma: Use of Signal Transducer and Activator of Transcription 3 as a Risk Factor for Poor Diagnosis.- Salivary Gland Tumors: Preoperative Tissue Characterization with Apparent Diffusion Coefficient Mapping.- Role of Human Papillomavirus in Tonsillar Cancer.- Quantitative Reverse Transcription–Polymerase Chain Reaction Based Assessment of the Candidate Biomarkers for Tongue Cancer Metastasis.- Nasopharyngeal Carcinoma (Retropharyngeal Lymph Node Metastasis): Spread Pattern, Prognosis, and Staging.- Retinoblastoma: Diagnosis, Treatment and Prognosis.- Thyroid Carcinoma.- Molecular Genetics of Thyroid Cancer.- Thyroid Cancer:Identification of Gene Expression Markers for Diagnosis.- Papillary Thyroid Carcinoma: Use of HBME1 and CK19 as Diagnostic Markers.- Papillary Thyroid Carcinoma: Detection of Copy Gain of Platelet Derived Growth Factor B Using Array Comparative Genomic Hybridization in Combination with Laser Capture Microdissection.- PET Imaging in Thyroid Carcinoma.- Metastasized Medullary Thyroid Carcinoma: Detection and Therapy Using Radiolabeled Gastrin Analogs.- Medullary Thyroid Carcinoma: Prognosis based on Stage of Disease and Age.- Overexpression of the Components of the Plasminogen Activating System as Prognostic Factors in Human Thyroid Carcinoma.
